Fig 3. hMDA-7 BSA-NPs enhance BXPC-3 and PANC-1 apoptosis.
BXPC-3 and PANC-1 cells, respectively, were transfected with no plasmid/nanoparticle (Control group), 20 μg blank BSA-NPs to a final concentration of 2 mg/mL (BSA-NPs group), 20 μg of empty pcDNA3.1 using the lipid transfection reagent (Empty vector group), 20 μg of pcDNA3.1-hMDA-7 using the lipid transfection reagent (hMDA-7 plasmid group), and 20 μg of BSA- hMDA-7-NPs to a final concentration of 2 mg/mL (hMDA-7 BSA-NPs group), and assessed for apoptosis by flow-cytometry. A and C, flow-cytograms of BXPC-3 and PANC-1 cells, respectively; B and D, quantitation of A and C, respectively. *p<0.05 compared to Control, BSA-NP, and Empty vector groups; #p<0.05 compared to the hMDA-7 plasmid group. All experiments were repeated three times. Data are mean±SD.